Primary malignant lymphoma of the brain: Demonstration of frequent p16 and p15 gene deletions

被引:17
|
作者
Kumanishi, T
Zhang, SJ
Ichikawa, T
Endo, S
Washiyama, K
机构
[1] Dept. of Molecular Neuropathology, Brain Research Institute, Niigata University, Niigata 951
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1996年 / 87卷 / 07期
关键词
lymphoma; brain tumor; tumor suppressor gene; CDK inhibitor gene; p16 gene deletion;
D O I
10.1111/j.1349-7006.1996.tb00279.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p16 (MTS-1) gene, a candidate tumor suppressor gene, was examined by means of Southern blot, PCR-SSCP (polymerase chain reaction-single-strand conformation polymorphism) and nucleotide analyses in 5 cases of primary malignant lymphoma of the brain. By Southern blot analysis, the p16 gene was found to be deleted in at least 4 cases, homozygously (3 cases) or hemizygously (1 case). The p15 (MTS-2) gene, another candidate tumor suppressor gene located in the vicinity of the p16 gene, to which it shows structural and functional similarity, was also found to be deleted in 4 cases. Our frequent detection (80%) of p16 and p15 gene deletions might suggest that these deletions are closely related to carcinogenesis in primary malignant lymphoma of the brain. SSCP and nucleotide analyses revealed no mutations of the p16 gene in any of the cases.
引用
收藏
页码:691 / 695
页数:5
相关论文
共 50 条
  • [31] Alteration of p16 and p15 genes in human uterine tumours
    R Nakashima
    M Fujita
    T Enomoto
    T Haba
    K Yoshino
    H Wada
    H Kurachi
    M Sasaki
    K Wakasa
    M Inoue
    G Buzard
    Y Murata
    British Journal of Cancer, 1999, 80 : 458 - 467
  • [32] Mutational analysis of the p15 and p16 genes in acute leukaemias
    Sill, H
    Aguiar, RCT
    Schmidt, H
    Hochhaus, A
    Goldman, JM
    Cross, NCP
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) : 681 - 683
  • [33] Alteration of p16 and p15 genes in human uterine tumours
    Nakashima, R
    Fujita, M
    Enomoto, T
    Haba, T
    Yoshino, K
    Wada, H
    Kurachi, H
    Sasaki, N
    Wakasa, K
    Inoue, M
    Buzard, G
    Murata, Y
    BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) : 458 - 467
  • [34] p16 mutations/deletions are not frequent events in prostate cancer
    Tamimi, Y
    Bringuier, PP
    Smit, F
    vanBokhoven, A
    Debruyne, FMJ
    Schalken, JA
    BRITISH JOURNAL OF CANCER, 1996, 74 (01) : 120 - 122
  • [35] Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia
    Yamada, Y
    Hatta, Y
    Murata, K
    Sugawara, K
    Ikeda, S
    Mine, M
    Maeda, T
    Hirakata, Y
    Kamihira, S
    Tsukasaki, K
    Ogawa, S
    Hirai, H
    Koeffler, HP
    Tomonaga, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1778 - 1785
  • [36] Frequent codeletion of p16/MTS1 and p15/IWTS2 and genetic alterations in p16/MTS1 in pancreatic tumors
    Naumann, M
    Savitskaia, N
    Eilert, C
    Schramm, A
    Kalthoff, H
    Schmiegel, W
    GASTROENTEROLOGY, 1996, 110 (04) : 1215 - 1224
  • [37] Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas
    Zhao, YS
    Zhang, SZ
    Fu, BY
    Xiao, CY
    CANCER GENETICS AND CYTOGENETICS, 1999, 112 (01) : 26 - 33
  • [38] Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers
    Packenham, JP
    Taylor, JA
    White, CM
    Anna, CH
    Barrett, JC
    Devereux, TR
    CLINICAL CANCER RESEARCH, 1995, 1 (07) : 687 - 690
  • [39] A study of p16 gene abnormality in 165 cases with malignant lymphoma
    Yao, Jin-Juan
    Li, Xiao-Qiu
    Xu, Liang-Zhong
    Shi, Zong-Gao
    Zhu, Wei-Ping
    Xu, Yue-Xiang
    Zheng, Ai-Hua
    Fudan University Journal of Medical Sciences, 2001, 28 (01): : 9 - 12
  • [40] DELETION OF THE P16 AND P15 GENES IN HUMAN BLADDER-TUMORS
    ORLOW, I
    LACOMBE, L
    HANNON, GJ
    SERRANO, M
    PELLICER, I
    DALBAGNI, G
    REUTER, VE
    ZHANG, ZF
    BEACH, D
    CORDONCARDO, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (20) : 1524 - 1529